You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

combination regimen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)

Recruiting
  • Hemophilia B
  • Sodium valproate extended-release tablets
  • Beijing, China
    PLA General Hospital
Jun 17, 2023

Acute Myeloid Leukemia Trial in Shenyang (rhTPO, Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
May 16, 2022

Gastric Cancer Stage IIIB-IIIC Trial in Shanghai (Pembrolizumab + SOX)

Recruiting
  • Gastric Cancer Stage IIIB-IIIC
  • Pembrolizumab + SOX
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 7, 2023

Orelabrutinib in Combination With Standard Treatment Regimen for

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Aug 23, 2023

SARS-CoV2 Infection, COVID-19 Trial (Combination regimen: Fluoxetine, Prednisolone, Ivermectin, Combination regimen:

Not yet recruiting
  • SARS-CoV2 Infection
  • COVID-19
  • Combination regimen: Fluoxetine, Prednisolone, Ivermectin
  • Combination regimen: Albendazole, Vitamin C
  • (no location specified)
Mar 16, 2022

Colorectal Cancer Trial in China (TQB2618 injection, Penpulimab injection, Anlotinib HCl capsules)

Not yet recruiting
  • Colorectal Cancer
  • TQB2618 injection
  • +2 more
  • Fuyang, Anhui, China
  • +14 more
Aug 23, 2023

Acute Myeloid Leukemia Trial in Shenyang (rhTPO)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
Feb 17, 2022

COVID-19 Trial in Ho Chi Minh City (KOVIR capsule combined with background treatment)

Not yet recruiting
  • COVID-19
  • KOVIR capsule combined with background treatment
  • Ho Chi Minh City, Vietnam
    Traditional Medicine Institute in Ho Chi Minh City
Jan 25, 2022

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

COVID-19 Trial in Ho Chi Minh City (TD0069 hard capsule, TD0069 Placebo)

Recruiting
  • COVID-19
  • TD0069 hard capsule
  • TD0069 Placebo
  • Ho Chi Minh City, Ho Chi Minh, Vietnam
    Traditional Medicine Institute in Ho Chi Minh City
Mar 16, 2022

Acute Myeloid Leukemia Trial in Kunming (Venetoclax in Combination With Azacitidine and HA Regimen)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax in Combination With Azacitidine and HA Regimen
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Jul 10, 2023

Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Newly Diagnosed Glioblastoma Trial in Suwon-si (GX-I7, Placebo)

Withdrawn
  • Newly Diagnosed Glioblastoma
  • GX-I7
  • Placebo
  • Suwon-si, Korea, Republic of
    St. Vincent Hospital
Mar 2, 2022

Polymyalgia Rheumatica Trial (Secukinumab 300 mg, Secukinumab 150 mg, Placebo to secukinumab)

Not yet recruiting
  • Polymyalgia Rheumatica
  • Secukinumab 300 mg
  • +2 more
  • (no location specified)
Mar 6, 2023

COVID-19 Trial in Ho Chi Minh City (KOVIR oral capsule, Placebo oral capsule)

Completed
  • COVID-19
  • KOVIR oral capsule
  • Placebo oral capsule
  • Ho Chi Minh City, Vietnam
    Traditional Medicine Institute in Ho Chi Minh City
Oct 16, 2021

Acute Myeloid Leukemia, Venetoclax Trial in Kunming (combination of venetoclax and HAA regimen)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • combination of venetoclax and HAA regimen
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
May 29, 2023

Females With PCOS on CPA/EE Combination Drug Regimen

Not yet recruiting
  • Periodontitis
  • +2 more
  • Cyproterone Acetate, Ethinyl Estradiol Drug Combination
  • +2 more
  • Rohtak, Haryana, India
    Post Graduate Institute of Dental Science
Nov 11, 2021

Gaucher Disease Type 1 Trial in Jerusalem (Enzyme replacement therapy for Gaucher disease in combination with altus care

Completed
  • Gaucher Disease Type 1
  • Enzyme replacement therapy for Gaucher disease in combination with altus care application
  • Jerusalem, Israel
    Hebrew university
Sep 18, 2023

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Jun 1, 2023

CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

Not yet recruiting
  • CLL/SLL
  • Orelabrutinib and BG
  • Wuhan, Hubei, China
  • +1 more
Jun 15, 2023

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))

Withdrawn
  • NSCLC Stage IV
  • combination regimen tremelimumab /durvalumab
  • platinum-based chemotherapy (SoC)
  • Gauting, Germany
    Asklepios Fachkliniken München-Gauting
Sep 26, 2022

Double Hit Lymphoma, Triple Hit Lymphoma Trial in Hangzhou (Selinexor+RCHOP)

Recruiting
  • Double Hit Lymphoma
  • Triple Hit Lymphoma
  • Hangzhou, Zhenjiang, China
    Zhejiang Cancer Hospital
Aug 2, 2023

Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover

Not yet recruiting
  • Metastatic Melanoma
  • +2 more
  • Lifileucel plus Pembrolizumab
  • Pembrolizumab with Optional Crossover Period
  • (no location specified)
Feb 13, 2023

HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

Active, not recruiting
Has Results
  • HIV-1 Infection
  • Doravirine, Tenofovir, Lamivudine
  • +4 more
  • (no location specified)
Sep 2, 2022